Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application

by Tom A. Mulder, Björn E. Wahlin, Anders Österborg, Marzia Palma
Published 2019-06-01

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

by Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, Bjorn E. Wahlin, Per-Ola Andersson, Karin E. Smedby
Published 2021-01-01